2022 Speakers

Aditya Raguram

PhD Student

David Liu Lab, Harvard University

Alexandra Crawley

Co-Founder & Senior Scientist

LifeEDIT

Amy Simon

Chief Medical Officer

Beam Therapeutics

Benjamin Oakes

Co-Founder & Chief Executive Officer

Scribe Therapeutics

Carlo Zambonelli

Senior Director – Analytical Sciences

Beam Therapeutics

Danilo Maddalo

Group Leader - Translational Oncology

Genentech

David Guay

Vice President Innovation and Technology

Feldan Therapeutics

Eric B. Kmiec

Executive Director & Chief Scientific Officer

ChristianaCare Gene Editing Institute

Guillaume Pavlovic

Head of Genetic Engineering and Model Validation Department

Institut Clinique De La Souris

Howard Wu

Founder & Chief Scientific Officer

Full Circles Therapeutics

Inge Yung-Chih Cheng

Principal Scientist

Pfizer

Ira Gotliv

Vice President – Preclinical Research

Emendo Biotherapeutics

Darren Hart

Senior Vice President, Development

Graphite Bio

Jeremy Duffield

Chief Scientific Officer

Prime Medicine

Joey Riepsaame

Head of Genome Engineering

University of Oxford

John Murphy

Chief Scientific Officer

Arbor Biotechnologies

Jonathan Yen

Director of Therapeutic Genome Engineering

St. Jude Children’s Research Hospital

Kiran Musunuru

Professor of Medicine Director

Perelman School of Medicine, University of Pennsylvania

Liron Walsh

Head of Development; In Vivo Programs

Intellia Therapeutics

Michael Maitland

Senior Director, Clinical Development

Intellia Therapeutics

Paul Donohoue

Senior Scientist – Platform Discovery Group Lead

Caribou Biosciences

Rafi Emmanuel

Senior Vice President - Research & Development

Emendo Biotherapeutics

Rajarshi Choudhury

Associate Director - Genomic Sciences

GSK

Rammohan Devulapally

Principal Scientist – Drug Delivery Chemistry and Nanoparticle Formulation Development

GenEdit

Roberto Nitsch

Associate Director

AstraZeneca

Samuel Du

MD-PhD Student

Krzysztof Palczewski Lab, University of California Irvine

Weston Miller

Vice President - Clinical Development